| Balance Sheets | 2025-09-30 | 2025-06-30 | ||
|---|---|---|---|---|
| Cash and cash equivalents | 6,950 | 4,030 | ||
| Restricted cash | 30 | 30 | ||
| Trade receivables | 252 | 115 | ||
| Prepaid expenses and other accounts receivable | 540 | 511 | ||
| Inventory | 2,243 | 2,206 | ||
| Total current assets | 10,015 | 6,892 | ||
| Property and equipment, net | 124 | 112 | ||
| Long-term trade receivables | 23 | - | ||
| Severance pay fund | 190 | 186 | ||
| Operating lease right-of-use assets | 125 | 145 | ||
| Intangible assets | 5,275 | 5,516 | ||
| Goodwill | 38,631 | 38,631 | ||
| Total non-current assets | 44,368 | 44,590 | ||
| Total assets | 54,383 | 51,482 | ||
| Loans | - | 1,975 | ||
| Deferred revenue | 0 | - | ||
| Trade payables | 492 | 270 | ||
| Other accounts payable and accrued expenses | 4,267 | 4,217 | ||
| Loans | 1,043 | - | ||
| Tranche financing liability | 2,000 | - | ||
| Warranty liability | 3,730 | - | ||
| Operating lease liabilities, current | 112 | 81 | ||
| Total current liabilities | 11,644 | 6,543 | ||
| Accrued severance pay | 260 | 232 | ||
| Operating lease liabilities, non-current | 15 | 69 | ||
| Warrant liability | - | 4,161 | ||
| Total liabilities | 11,919 | 11,005 | ||
| Preferred stock value-Series CPreferred Stock | 0 | 0 | ||
| Preferred stock value-Series XPreferred Stock | 0 | 0 | ||
| Preferred stock value-Series HPreferred Stock | 0 | - | ||
| Common stock of 0.001 par value - authorized 40,000,000 shares at september 30, 2025 and december 31, 2024, respectively issued and outstanding 1,011,086 and 37,894 shares at september 30, 2025 and december 31, 2024, respectively | 1 | 8 | ||
| Additional paid-in capital | 119,408 | 116,542 | ||
| Accumulated other comprehensive income | -87 | -85 | ||
| Accumulated deficit | -76,858 | -75,988 | ||
| Total stockholders equity | 42,464 | 40,477 | ||
| Total liabilities and stockholders equity | 54,383 | 51,482 | ||
NanoVibronix, Inc. (NAOV)
NanoVibronix, Inc. (NAOV)